Jounce Therapeutics Inc. (JNCE) Climbed 20.79% or 0.84 To Price $4.88 On Thursday


Jounce Therapeutics Inc. (JNCE) climbed 20.79% or 0.84 to $4.88. It is approximately 616047 shares traded, which is 209.66% compare to the average total volume 293835. The market cap of JNCE is $159.22 million. The year to date change is -49.06%. The 52 week price range is from $4.03 to $29.25. Price of JNCE have changed -16.70% during last week. It have changed -35.77% over last month, -42.78% over last 3 months, -80.38% over last 6 months and -71.63% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 6.52. It is 33.61% above current price. The 200-day Moving Averages for JNCE is 13.60. It is 178.69% above current price. The 52-week High is 29.25. It is 499.39% from the current price. The 52-week Low is 4.03. It is -17.42% from current price.

There are some statistics of JNCE. It is has market cap $159.22 million. The share outstanding is 32.63 million. The average volume is 293835. The revenue is 18.08M. The percent of top 15 Institution holding is 43.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -21.94%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -10.57%.


Tags:

Share this post